{"id":"W4388668160","doi":"10.1136/jnnp-2023-332758","title":"Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)","year":2023,"lang":"en","type":"editorial","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Natalizumab; Multiple sclerosis; Relapsing remitting; Dosing; Medicine; Drug; Therapeutic drug monitoring; Internal medicine; Pharmacology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009477307,0.001599703,0.003942679,0.0005415659,0.0006677706,0.002544184,0.001948869,0.005161888,0.005045075],"category_scores_gemma":[0.00901316,0.0008138834,0.002749512,0.0005715801,0.0005292065,0.001014019,0.0003405863,0.007232907,0.001302474],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001318695,"about_ca_system_score_gemma":0.002772578,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001318999,"about_ca_topic_score_gemma":0.002824255,"domain_scores_codex":[0.9982737,0.0006641022,0.0002850918,0.0002450742,0.0004047398,0.0001272233],"domain_scores_gemma":[0.994199,0.003413635,0.0005850112,0.0001850966,0.0008438026,0.0007733548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.11469,0.0009850045,0.0008520111,0.008529984,0.006492285,0.0007481798,0.00006247054,0.0004850029,0.002260065,0.001535729,0.7929664,0.07039287],"study_design_scores_gemma":[0.4416835,0.01956887,0.01460009,0.004366751,0.01994384,0.0008457461,0.000148383,0.003435466,0.002293136,0.002495639,0.4903828,0.0002358495],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.01633553,0.08479847,0.001046289,0.05274599,0.8335542,0.001015629,0.002325897,0.0003331483,0.007844778],"genre_scores_gemma":[0.08668718,0.07635047,0.004729636,0.1464444,0.6286559,0.002191357,0.002564788,0.000251049,0.05212516],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.009477307,"threshold_uncertainty_score":0.05012137,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04902397906515468,"score_gpt":0.3216518491268284,"score_spread":0.2726278700616737,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}